978 related articles for article (PubMed ID: 29100075)
1. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas.
;
Cell; 2017 Nov; 171(4):950-965.e28. PubMed ID: 29100075
[TBL] [Abstract][Full Text] [Related]
2. T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas.
Pollack SM; He Q; Yearley JH; Emerson R; Vignali M; Zhang Y; Redman MW; Baker KK; Cooper S; Donahue B; Loggers ET; Cranmer LD; Spraker MB; Seo YD; Pillarisetty VG; Ricciotti RW; Hoch BL; McClanahan TK; Murphy E; Blumenschein WM; Townson SM; Benzeno S; Riddell SR; Jones RL
Cancer; 2017 Sep; 123(17):3291-3304. PubMed ID: 28463396
[TBL] [Abstract][Full Text] [Related]
3. Can DNA Methylation Profiling Classify Histologic Subtypes and Grades in Soft Tissue Sarcoma?
Kim H; Joo MW; Yoon J; Park HS; Kim JH; Lee JH; Kim SH; Lee SK; Chung YG; Cho YJ
Clin Orthop Relat Res; 2024 Mar; 482(6):1028-37. PubMed ID: 38517415
[TBL] [Abstract][Full Text] [Related]
4. Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma.
Cheng L; Pandya PH; Liu E; Chandra P; Wang L; Murray ME; Carter J; Ferguson M; Saadatzadeh MR; Bijangi-Visheshsaraei K; Marshall M; Li L; Pollok KE; Renbarger JL
BMC Med Genomics; 2019 Jan; 12(Suppl 1):23. PubMed ID: 30704460
[TBL] [Abstract][Full Text] [Related]
5. Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy.
Barretina J; Taylor BS; Banerji S; Ramos AH; Lagos-Quintana M; Decarolis PL; Shah K; Socci ND; Weir BA; Ho A; Chiang DY; Reva B; Mermel CH; Getz G; Antipin Y; Beroukhim R; Major JE; Hatton C; Nicoletti R; Hanna M; Sharpe T; Fennell TJ; Cibulskis K; Onofrio RC; Saito T; Shukla N; Lau C; Nelander S; Silver SJ; Sougnez C; Viale A; Winckler W; Maki RG; Garraway LA; Lash A; Greulich H; Root DE; Sellers WR; Schwartz GK; Antonescu CR; Lander ES; Varmus HE; Ladanyi M; Sander C; Meyerson M; Singer S
Nat Genet; 2010 Aug; 42(8):715-21. PubMed ID: 20601955
[TBL] [Abstract][Full Text] [Related]
6. Integrated molecular characterization of adult soft tissue sarcoma for therapeutic targets.
Kim J; Kim JH; Kang HG; Park SY; Yu JY; Lee EY; Oh SE; Kim YH; Yun T; Park C; Cho SY; You HJ
BMC Med Genet; 2018 Dec; 19(Suppl 1):216. PubMed ID: 30598078
[TBL] [Abstract][Full Text] [Related]
7. Multi-omics analysis of copy number variations of RNA regulatory genes in soft tissue sarcoma.
Wang X; Han Y; Li J; Hong D; Xue Z; Huang H; Du Z; Hou Y; Li H; Li H; Liao H; Xie X; Ding C
Life Sci; 2021 Jan; 265():118734. PubMed ID: 33166590
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of prognostic markers in sarcomas base on a multi-omics analysis.
Song Y; Yang K; Sun T; Tang R
BMC Med Genomics; 2021 Jan; 14(1):31. PubMed ID: 33509178
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential.
Francis P; Namløs HM; Müller C; Edén P; Fernebro J; Berner JM; Bjerkehagen B; Akerman M; Bendahl PO; Isinger A; Rydholm A; Myklebost O; Nilbert M
BMC Genomics; 2007 Mar; 8():73. PubMed ID: 17359542
[TBL] [Abstract][Full Text] [Related]
10. Establishment and Characterization of Histologically and Molecularly Stable Soft-tissue Sarcoma Xenograft Models for Biological Studies and Preclinical Drug Testing.
Cornillie J; Wozniak A; Li H; Wang Y; Boeckx B; Gebreyohannes YK; Wellens J; Vanleeuw U; Hompes D; Stas M; Sinnaeve F; Wafa H; Lambrechts D; Debiec-Rychter M; Sciot R; Schöffski P
Mol Cancer Ther; 2019 Jun; 18(6):1168-1178. PubMed ID: 30962320
[TBL] [Abstract][Full Text] [Related]
11. Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas.
Groisberg R; Hong DS; Holla V; Janku F; Piha-Paul S; Ravi V; Benjamin R; Kumar Patel S; Somaiah N; Conley A; Ali SM; Schrock AB; Ross JS; Stephens PJ; Miller VA; Sen S; Herzog C; Meric-Bernstam F; Subbiah V
Oncotarget; 2017 Jun; 8(24):39254-39267. PubMed ID: 28424409
[TBL] [Abstract][Full Text] [Related]
12. Establishment and molecular characterisation of seven novel soft-tissue sarcoma cell lines.
Salawu A; Fernando M; Hughes D; Reed MW; Woll P; Greaves C; Day C; Alhajimohammed M; Sisley K
Br J Cancer; 2016 Oct; 115(9):1058-1068. PubMed ID: 27560552
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy for sarcomas.
Nakata E; Fujiwara T; Kunisada T; Ito T; Takihira S; Ozaki T
Jpn J Clin Oncol; 2021 Apr; 51(4):523-537. PubMed ID: 33611603
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Genomic Profiling of Adult Renal Sarcomas Provides Insight into Disease Biology and Opportunities for Targeted Therapies.
Yakirevich E; Madison R; Fridman E; Mangray S; Carneiro BA; Lu S; Cooke M; Bratslavsky G; Webster J; Ross JS; Ali SM
Eur Urol Oncol; 2021 Apr; 4(2):282-288. PubMed ID: 31412008
[TBL] [Abstract][Full Text] [Related]
15. Profiling of potential driver mutations in sarcomas by targeted next generation sequencing.
Andersson C; Fagman H; Hansson M; Enlund F
Cancer Genet; 2016 Apr; 209(4):154-60. PubMed ID: 26987750
[TBL] [Abstract][Full Text] [Related]
16. A genomic survey of sarcomas on sun-exposed skin reveals distinctive candidate drivers and potentially targetable mutations.
Miller TI; Zoumberos NA; Johnson B; Rhodes DR; Tomlins SA; Chan MP; Andea AA; Lucas DR; McHugh JB; Smith N; Harms KL; Brewer C; Saleh J; Patel RM; Harms PW
Hum Pathol; 2020 Aug; 102():60-69. PubMed ID: 32540221
[TBL] [Abstract][Full Text] [Related]
17. Subclassification of pleomorphic sarcomas: How and why should we care?
Hornick JL
Ann Diagn Pathol; 2018 Dec; 37():118-124. PubMed ID: 30340082
[TBL] [Abstract][Full Text] [Related]
18. TP53 in bone and soft tissue sarcomas.
Thoenen E; Curl A; Iwakuma T
Pharmacol Ther; 2019 Oct; 202():149-164. PubMed ID: 31276706
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation profiling distinguishes Ewing-like sarcoma with EWSR1-NFATc2 fusion from Ewing sarcoma.
Koelsche C; Kriegsmann M; Kommoss FKF; Stichel D; Kriegsmann K; Vokuhl C; Grünewald TGP; Romero-Pérez L; Kirchner T; de Alava E; Diaz-Martin J; Hartmann W; Baumhoer D; Antonescu CR; Szuhai K; Flucke U; Dirksen U; Pfister SM; Jones DTW; Mechtersheimer G; von Deimling A
J Cancer Res Clin Oncol; 2019 May; 145(5):1273-1281. PubMed ID: 30895378
[TBL] [Abstract][Full Text] [Related]
20. Sarcomas: Immune biomarker expression and checkpoint inhibitor trials.
Zhu MMT; Shenasa E; Nielsen TO
Cancer Treat Rev; 2020 Dec; 91():102115. PubMed ID: 33130422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
